Table 3.
The contribution of clinical factors in vignettes to initial risk estimates listed according to how often they were considered “important”.
| Factor | Important | Somewhat important | Neither important nor unimportant | Somewhat unimportant | Unimportant |
|---|---|---|---|---|---|
| Performance status | 212 (72) | 70 (24) | 8 (3) | 3 (1) | 1 (0) |
| DLCO | 189 (64) | 81 (28) | 12 (4) | 3 (1) | 9 (3) |
| FEV1 | 156 (53) | 118 (40) | 5 (2) | 6 (2) | 9 (3) |
| Smoking status | 147 (50) | 122 (42) | 15 (5) | 5 (2) | 5 (2) |
| Clinical impression | 146 (50) | 135 (46) | 9 (3) | 4 (1) | 0 (0) |
| Cardiac status | 123 (42) | 134 (46) | 25 (9) | 9 (3) | 3 (1) |
| Cancer stage | 105 (36) | 132 (45) | 44 (15) | 9 (3) | 4 (1) |
| Renal function | 35 (12) | 161 (55) | 71 (24) | 15 (5) | 12 (4) |
| Age | 26 (9) | 205 (70) | 32 (11) | 25 (9) | 6 (2) |
| Obesity | 21 (7) | 171 (58) | 64 (22) | 21 (7) | 17 (6) |
| Diabetes | 20 (7) | 144 (49) | 79 (27) | 25 (9) | 26 (9) |
| Peripheral vascular disease | 19 (6) | 178 (61) | 64 (22) | 19 (6) | 14 (5) |
| Hypertension | 10 (3) | 115 (39) | 118 (40) | 30 (10) | 21 (7) |
Numbers in parentheses represent percentages. DLCO: Diffusing capacity of the lung for carbon monoxide; FEV1: forced expiratory volume in the first second